New marketing authorizations for the Bulgarian territory – medicinal products for the treatment of diseases in the cardiovascular system and digestive system, diabetes and metabolism. Marketing authorization for antibiotics for the territory of Georgia.

Audits by the National Drug Agency have confirmed compliance with international Good Manufacturing Practice (GMP) standards at the two manufacturing plants in Plovdiv and Varna. The scope of the new certifications includes the new granulation line put into operation in  2022, as well as the production of dosage forms in capsules.